Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02616406 · ClinicalTrials.gov registry record
Objective Measure of Recovery After Outpatient Surgery
A clinical trial, sponsored by Mayo Clinic.
- Completed
- Registry status
- 5
- Enrollment target
NCT02616406: Completed study, sponsored by Mayo Clinic.
NCT02616406 is a clinical trial that has completed, run by Mayo Clinic. The registered enrollment target is 5 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02616406 has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- 5 participants
- Enrollment target
Study Summary
This is a study using wearable monitoring devices, patient activity and sleep patterns to monitor pre and post operative following outpatient inguinal hernia surgery to determine when these parameters return to baseline.
Interventions
- DEVICE GENEactiv
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5 participants |
| Start Date | 2015-11 |
| Est. Completion | 2019-07 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02616406
The ClinicalTrials.gov registry entry for NCT02616406 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 5 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which GENEactiv is the first listed.
NCT02616406 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02616406 about?
NCT02616406 is a clinical study titled "Objective Measure of Recovery After Outpatient Surgery". This is a study using wearable monitoring devices, patient activity and sleep patterns to monitor pre and post operative following outpatient inguinal hernia surgery to determine when these parameters return to baseline.
What is the current status of trial NCT02616406?
This trial is currently completed. The enrollment target is 5 participants. The study started on 2015-11. Estimated completion is 2019-07.
What interventions are being tested in trial NCT02616406?
The interventions under investigation include: GENEactiv (DEVICE).
Who is sponsoring clinical trial NCT02616406?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.